Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stempeucel in Alcoholic Liver Cirrhosis
NCT01591200Phase 2Completed
- Sponsor
- Stempeutics Research
- Start
- Jun 2012
- Primary completion
- Apr 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Stempeucel in alcoholic liver cirrhosis, sponsored by Stempeutics Research. Started Jun 2012; status: completed.
02
Drugs
Stempeucel
03
Conditions
alcoholic liver cirrhosis
Beyond the preview
Go deeper on NCT01591200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591200.